Metraipolis › archive › dc_c91ef036c8fd

Ferroptosis-Based Nanotherapeutic Strategies to Overcome Temozolomide Resistance in Glioblastoma: A Systematic Review and Meta-Analysis — Europe PMC PMID:42041713

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42041713
DOI: 10.3390/curroncol33040194
License (as archived): solo-consultazione
Archived: 2026-11-03T15:54:33.449Z
SHA-256 of the archived text: cc84df46f3f610297186f83d35ef7da909e395090a998d9318a62234c7acafc5
Stable URL of this page: https://metraipolis.com/documento/dc_c91ef036c8fd

How to cite

Ferroptosis-Based Nanotherapeutic Strategies to Overcome Temozolomide Resistance in Glioblastoma: A Systematic Review and Meta-Analysis — Europe PMC PMID:42041713 — Europe PMC (en), https://europepmc.org/article/MED/42041713 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c91ef036c8fd (Metraipolis archive dc_c91ef036c8fd, sha256 cc84df46f3f610297186f83d35ef7da909e395090a998d9318a62234c7acafc5)

BibTeX

@misc{dcc91ef036c8fd,
  title = {Ferroptosis-Based Nanotherapeutic Strategies to Overcome Temozolomide Resistance in Glioblastoma: A Systematic Review and Meta-Analysis — Europe PMC PMID:42041713},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42041713},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c91ef036c8fd; sha256 cc84df46f3f610297186f83d35ef7da909e395090a998d9318a62234c7acafc5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42041713. Agents can read the archived copy with the MCP tool read_document.